Demethylases in tumors and the tumor microenvironment: Key modifiers of N6-methyladenosine methylation
Junchen Guo,
No information about this author
Liang Zhao,
No information about this author
Meiqi Duan
No information about this author
et al.
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
174, P. 116479 - 116479
Published: March 26, 2024
RNA
methylation
modifications
are
widespread
in
eukaryotes
and
prokaryotes,
with
N
Language: Английский
Hotspots and trends in gastric cancer stem cell research: a visualization and bibliometric analysis
Jinfeng Liu,
No information about this author
Xiaoxu Han,
No information about this author
Qingyi Wang
No information about this author
et al.
Frontiers in Oncology,
Journal Year:
2025,
Volume and Issue:
15
Published: March 5, 2025
Gastric
cancer
(GC)
is
a
type
of
malignant
tumor
that
seriously
endangers
human
health.
As
the
understanding
mechanisms
underlying
gastric
deepens,
in
recent
years,
investigations
on
stem
cells
(GCSCs)
have
garnered
significant
interest.
They
are
pivotal
onset,
progression,
recurrence,
and
pharmacoresistance
GC.
Comprehensive
research
GCSCs
expected
to
provide
new
strategies
for
diagnosis
treatment
This
article
endeavors
comprehensively
assess
current
status
future
trends
through
bibliometric
analysis,
thereby
providing
valuable
reference
further
-
depth
studies
this
field.
English
language
academic
journals
related
Web
Science
database
were
retrieved.
Subsequently,
VOSviewer
was
utilized
conduct
network
collinear
analysis
exported
source
institutions,
literature
authors,
references,
keywords.
And
CiteSpace
used
perform
statistical
annual
publication
count,
keyword
clustering,
burst.
A
total
3882
documents
met
criteria
incorporated.
The
quantity
published
papers
has
shown
consistent
upward
trend
annually
since
2003.
Among
authors
literature,
multiple
stable
core
author
groups
represented
by
Zhu,
Wei,
Wang,
Mei,
Xu,
Wenrong,
etc.
been
formed.
There
335
associated
institutions
total.
Japan
National
Cancer
Center
strongest
relevance
largest
number
papers.
7
clustering
labels
formed
among
keywords,
including
main
modules
such
as
activation,
cells,
DNA
content
aneuploidy,
expression.
25
burst
keywords
generated,
past
two
years
include
mesenchymal
drug
resistance,
proliferation,
emergence
references
indicates
eight
cited
up
now
focus
research.
overview
30
visually
presented
visual
maps.
In
decade,
scholars'
field
gradually
intensified,
development
good.
Through
deeper
study
mechanism,
intervention
will
be
promising
approach
GC
patients.
hot
topic
still
deserves
more
attention
future.
Language: Английский
FTO promotes gastric cancer progression by modulating MAP4K4 expression via demethylation in an m6A-dependent manner
Medical Oncology,
Journal Year:
2024,
Volume and Issue:
41(5)
Published: April 20, 2024
Language: Английский
Meta-analysis of FTO expression on the clinicopathologic characteristics and prognosis of gastric cancer
Ciba Zhu,
No information about this author
Mingxu Da,
No information about this author
Ziyao Wu
No information about this author
et al.
Medicine,
Journal Year:
2024,
Volume and Issue:
103(39), P. e35714 - e35714
Published: Sept. 27, 2024
Background:
Fat
mass
and
obesity-related
gene
(FTO)
is
aberrantly
expressed
in
various
cancers
including
highly
gastric
cancer
tissues.
The
aim
of
this
meta-analysis
was
to
explore
the
effect
FTO
expression
on
clinicopathological
prognostic
outcome
cancer.
Methods:
China
National
Knowledge
Infrastructure
(CNK),
Wanfang
database,
VIP
Chinese
biomedical
literature
database
(CBM),
PubMed,
Web
Science,
Cochrane
library
EMBASE
were
searched
screen
literatures
according
inclusion
criteria.
search
time
establishment
until
May
2023.
two
researchers
independently
screened
literature,
extracted
pathological
data,
conducted
Newcastle–Ottawa
scale
(NOS)
quality
evaluation.
Analyze
correlation
between
indicators
patients
impact
prognosis,
use
Stata
12.0,
software
for
Meta-analysis.
Results:
A
total
1619
studied
study.
results
Meta-analysis
showed
that
higher
levels
associated
with
TMN
stage
(OR
=
1.83,
95%
CI:
1.11–3.03,
P
.019),
liver
metastases
3.73,
1.49–9.31,
.005),
vascular
invasion
2.22,
1.36–3.61,
.001),
poorer
overall
survival
(OS)
(HR
0.46,
0.34–0.58,
<
.001)
recurrence-free
0.56,
0.40–0.73,
patients.
There
no
significant
relationship
degree
differentiation
1.08,
0.49–2.35,
.852),
age
0.89,
0.71–1.11,
.306),
gender
0.92,
0.74–1.14,
.432).
Conclusion:
High
risk
distant
poor
prognosis
may
be
a
potential
biomarker
cancer,
but
due
limited
number
above
need
further
research.
Language: Английский